The collaboration between COEXYA and AQUILAB naturally provides complementarity in the realm of multicenter clinical studies: COEXYA offers the ConSore solution for creating patient cohorts, while AQUILAB provides the Onco Place solution for managing clinical trials.
For David Gibon, leader of Aquilab
"This collaboration allows Aquilab to strengthen its expertise in the field of data and AI to accelerate its development in predictive medicine. Aquilab and Coexya share common values and clients. These synergies will enable us to offer new solutions, serving better treatments for cancer patients."
